Enfusion Inc.

ENFN

Offer Price Offer Size 3-Year Outlook Volatility 1st Day Turnover
$17.00 18,800,000 Positive High 70.53%

Offering Team

Deal Managers

  • Morgan Stanley
  • Goldman Sachs
  • Bank of America Merrill Lynch

Lawyers

  • Davis Polk & Wardwell LLP

Auditors

  • Ernst & Young LLP

Pre-IPO Investors

Investors

  • Google Ventures
  • Intel Ventures
  • Patricoff Ventures
  • Kleiner Perkins

Pre-IPO Holdings(%)

  • 30
  • 20
  • 05
  • 18

Deal Highlights

Enfusion is a global, high-growth software-as-a-service, or SaaS, provider focused on transforming the investment management industry. Our solution is designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. We simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source More

Deal Tracker

Investors

Filing

20 Oct, 2021

Offer

21 Oct, 2021

Look Ahead

Lock Up Expiry

21 Apr, 2022

Earning

Nov 1, 2018

IPO Terms

Offer Price $17.00
Offer Size 18M

Market Sentiments

Stock Price